The thromboxane synthase and receptor signaling pathway in cancer: An emerging paradigm in cancer progression and metastasis

Cancer and Metastasis Reviews

Volumn 30, Issue 3-4, 2011, Pages 397-408

  Ekambaram, Prasanna ^a   Lambiv, Wanyu ^a   Cazzolli, Rosanna ^b   Ashton, Anthony W ^b   Honn, Kenneth V ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Angiogenesis; Apoptosis; Cancer progression; Cell migration; Cyclooxygenase; Metastasis; Thromboxane receptor; Thromboxane synthase

Indexed keywords

CYCLOOXYGENASE 2; PROSTANOID RECEPTOR; THROMBOXANE SYNTHASE;

BLADDER CANCER; BRAIN CANCER; BREAST CANCER; CANCER GROWTH; COLON CANCER; HUMAN; LUNG CANCER; METASTASIS; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; CELL MOVEMENT; DISEASE PROGRESSION; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, THROMBOXANE; SIGNAL TRANSDUCTION; THROMBOXANE A2; THROMBOXANE-A SYNTHASE;

EID: 83855164044     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-011-9297-9     Document Type: Review

References (109)

1. M Hamberg J Svensson B Samuelsson 1975 Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides Proceedings of the National Academy of Sciences of the United States of America 72 8 2994 2998 1059088 1:CAS:528:DyaE2MXlvFSrur4%3D
2. S Moncada P Needleman S Bunting JR Vane 1976 Prostaglandin endoperoxide and thromboxane generating systems and their selective inhibition Prostaglandins 12 3 323 335 968048 1:CAS:528:DyaE28XlsFGnsrg%3D
3. EM Smyth 2010 Thromboxane and the thromboxane receptor in cardiovascular disease Clinical Lipidology 5 2 209 219 10.2217/clp. 10.11 20543887 1:CAS:528:DC%2BC3cXjvVKgs78%3D
4. P Needleman M Minkes A Raz 1976 Thromboxanes: Selective biosynthesis and distinct biological properties Science 193 4248 163 165 945611 1:CAS:528:DyaE28XksFyhsb8%3D
5. P Needleman S Moncada S Bunting JR Vane M Hamberg B Samuelsson 1976 Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides Nature 261 5561 558 560 934294 1:CAS:528:DyaE28XltFymsbs%3D
6. PV Halushka CJ Allan KL Davis-Bruno 1995 Thromboxane A2 receptors Journal of Lipid Mediators and Cell Signalling 12 2-3 361 378 8777579 1:CAS:528:DyaK28XivFKkuw%3D%3D
7. RL Jones NH Wilson RA Armstrong 1985 Characterization of thromboxane receptors in human platelets Advances in Experimental Medicine and Biology 192 67 81 3010674 1:CAS:528:DyaL2sXksVSkuw%3D%3D
8. DJ Fitzgerald L Roy F Catella GA FitzGerald 1986 Platelet activation in unstable coronary disease The New England Journal of Medicine 315 16 983 989 10.1056/nejm198610163151602 3531859 1:STN:280:DyaL2s%2FhsVKisg%3D%3D
9. SD Katugampola AP Davenport 2001 Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartan British Journal of Pharmacology 134 7 1385 1392 10.1038/sj.bjp. 0704416 11724743 1:CAS:528:DC%2BD3MXptVGgs7s%3D
10. GG Neri Serneri GF Gensini R Abbate C Mugnaini S Favilla C Brunelli, et al. 1981 Increased fibrinopeptide A formation and thromboxane A2 production in patients with ischemic heart disease: Relationships to coronary pathoanatomy, risk factors, and clinical manifestations American Heart Journal 101 2 185 194 6451162 1:STN:280:DyaL3M7jtVGmtw%3D%3D
11. S Fuse T Kamiya 1994 Plasma thromboxane B2 concentration in pulmonary hypertension associated with congenital heart disease Circulation 90 6 2952 2955 7994842 1:STN:280:DyaK2M%2FoslWnsQ%3D%3D
12. P Gresele H Deckmyn GG Nenci J Vermylen 1991 Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic disorders Trends in Pharmacological Sciences 12 4 158 163 1829559 1:CAS:528:DyaK3MXlt1Ohtb0%3D
13. T Kobayashi Y Tahara M Matsumoto M Iguchi H Sano T Murayama, et al. 2004 Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice The Journal of Clinical Investigation 114 6 784 794 10.1172/jci21446 15372102 1:CAS:528:DC%2BD2cXnslWiuro%3D
14. JL Mehta D Lawson P Mehta T Saldeen 1988 Increased prostacyclin and thromboxane A2 biosynthesis in atherosclerosis Proceedings of the National Academy of Sciences of the United States of America 85 12 4511 4515 3132716 1:CAS:528:DyaL1cXkslWgtL4%3D
15. JT Willerson SK Yao JJ Ferguson HV Anderson P Golino LM Buja 1991 Unstable angina pectoris and the progression to acute myocardial infarction. Role of platelets and platelet-derived mediators Texas Heart Institute Journal 18 4 243 247 15227406 1:STN:280:DC%2BD2czisFOmsA%3D%3D
16. R Lariviere C Moreau ME Rodrigue M Lebel 2004 Thromboxane blockade reduces blood pressure and progression of renal failure independent of endothelin-1 in uremic rats Prostaglandins, Leukotrienes, and Essential Fatty Acids 71 2 103 109 10.1016/j.plefa.2003.12.021 15207526 1:CAS:528: DC%2BD2cXltVCis7w%3D
17. JT Willerson LM Buja 1990 Potential of combined thromboxane A2 and serotonin antagonists to prevent the development of unstable angina and acute myocardial infarction Texas Heart Institute Journal 17 3 157 164 15227166 1:STN:280:DC%2BD2czisFKkuw%3D%3D
18. JT Willerson P Golino J Eidt SK Yao LM Buja 1990 Potential usefulness of combined thromboxane A2 and serotonin receptor blockade for preventing the conversion from chronic to acute coronary artery disease syndromes The American Journal of Cardiology 66 16 48G 53G 2146868 1:STN:280:DyaK3M%2FltFantA%3D%3D
19. M Haurand V Ullrich 1985 Isolation and characterization of thromboxane synthase from human platelets as a cytochrome P-450 enzyme Journal of Biological Chemistry 260 28 15059 15067 2999104 1:CAS:528:DyaL2MXlslCntL0%3D
20. K Ohashi KH Ruan RJ Kulmacz KK Wu LH Wang 1992 Primary structure of human thromboxane synthase determined from the cDNA sequence Journal of Biological Chemistry 267 2 789 793 1730669 1:CAS:528:DyaK3sXhsVansL8%3D
21. RF Shen HH Tai 1998 Thromboxanes: Synthase and receptors Journal of Biomedical Science 5 3 153 172 9678486 1:CAS:528:DyaK1cXks1yisL4%3D
22. C Yokoyama A Miyata H Ihara V Ullrich T Tanabe 1991 Molecular cloning of human platelet thromboxane A synthase Biochemical and Biophysical Research Communications 178 3 1479 1484 1714723 1:CAS:528:DyaK38Xit12gsr8%3D
23. T Tanabe V Ullrich 1995 Prostacyclin and thromboxane synthases Journal of Lipid Mediators and Cell Signalling 12 2-3 243 255 8777569 1:CAS:528: DyaK28XivFKluw%3D%3D
24. M Hirata Y Hayashi F Ushikubi Y Yokota R Kageyama S Nakanishi, et al. 1991 Cloning and expression of cDNA for a human thromboxane A2 receptor Nature 349 6310 617 620 10.1038/349617a0 1825698 1:CAS:528:DyaK3MXltVOgu7Y%3D
25. MK Raychowdhury M Yukawa LJ Collins SH McGrail KC Kent JA Ware 1994 Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor Journal of Biological Chemistry 269 30 19256 19261 8034687 1:CAS:528:DyaK2cXlvFOhu78%3D [Comparative Study]
26. BT Kinsella 2001 Thromboxane A2 signalling in humans: A 'Tail' of two receptors Biochemical Society Transactions 29 Pt 6 641 654 11709048 1:CAS:528:DC%2BD3MXpt1Crsrg%3D
27. SM Miggin BT Kinsella 1998 Expression and tissue distribution of the mRNAs encoding the human thromboxane A2 receptor (TP) alpha and beta isoforms Biochimica et Biophysica Acta 1425 3 543 559 9838218 1:CAS:528: DyaK1cXns1KltL0%3D [Research Support, Non-U.S. Gov't]
28. N Nakahata 2008 Thromboxane A2: Physiology/pathophysiology, cellular signal transduction and pharmacology Pharmacology and Therapeutics 118 1 18 35 10.1016/j.pharmthera.2008.01.001 18374420 1:CAS:528:DC%2BD1cXlvVSqsbY%3D
29. T Namba S Narumiya 1993 Thromboxane A2 receptor; structure, function and tissue distribution Nihon Rinsho 51 1 233 240 8433523 1:STN:280: DyaK3s7msVCrsg%3D%3D
30. KV Honn RS Bockman LJ Marnett 1981 Prostaglandins and cancer: A review of tumor initiation through tumor metastasis Prostaglandins 21 5 833 864 6280245 1:CAS:528:DyaL3MXls1KntbY%3D
31. KV Honn WD Busse BF Sloane 1983 Prostacyclin and thromboxanes. Implications for their role in tumor cell metastasis Biochemical Pharmacology 32 1 1 11 6338880 1:CAS:528:DyaL3sXhtVWhsLk%3D
32. Menter, D. G., Neagos, J., Dunn, R., Pallazo, T. T., Chen, T., Taylor, J. D. et al. (1982). Tumor Cell induced Platelet aggregration: Inhibition by prostacylin, thromboxane A2 and phosphodiesterase inhibitors. In T. J. Powles, R. S. Bockman, K. V.Honn, P. W. Ramwell (Ed.), Prostaglandins and cancer (pp. 369-374). New York: Alan Liss, Inc.
33. D Nie KV Honn 2002 Cyclooxygenase, lipoxygenase and tumor angiogenesis Cellular and Molecular Life Sciences 59 5 799 807 12088280 1:CAS:528: DC%2BD38XlvFequ7w%3D
34. KV Honn J Meyer 1981 Thromboxanes and prostacyclin: Positive and negative modulators of tumor growth Biochemical and Biophysical Research Communications 102 4 1122 1129 6274330 1:CAS:528:DyaL38XivVemtg%3D%3D
35. U.S.C.S.W.Group (2010). United States Cancer Statistics: 1999-2007 Incidence and Mortality Web-based Report: Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute.
36. I Bairati F Meyer Y Fradet L Moore 1998 Dietary fat and advanced prostate cancer The Journal of Urology 159 4 1271 1275 9507851 1:CAS:528: DyaK1cXms1equrs%3D [Research Support, Non-U.S. Gov't]
37. DP Rose JM Connolly 1992 Dietary fat, fatty acids and prostate cancer Lipids 27 10 798 803 1435098 1:CAS:528:DyaK38Xmtlaku78%3D [Review]
38. DW West ML Slattery LM Robison TK French AW Mahoney 1991 Adult dietary intake and prostate cancer risk in Utah: A case-control study with special emphasis on aggressive tumors Cancer Causes & Control 2 2 85 94 1:STN:280:DyaK3MzjvVCjtg%3D%3D [Research Support, U.S. Gov't, P.H.S.]
39. S Gupta M Srivastava N Ahmad K Sakamoto DG Bostwick H Mukhtar 2001 Lipoxygenase-5 is overexpressed in prostate adenocarcinoma Cancer 91 4 737 743 11241241 1:CAS:528:DC%2BD3MXhsFCrtLo%3D
40. D Nie M Che D Grignon K Tang KV Honn 2001 Role of eicosanoids in prostate cancer progression Cancer Metastasis Reviews 20 3-4 195 206 12085962 1:CAS:528:DC%2BD38XkvVWqsrg%3D
41. D Nie GG Hillman T Geddes K Tang C Pierson DJ Grignon, et al. 1999 Platelet-type 12-lipoxygenase regulates angiogenesis in human prostate carcinoma Advances in Experimental Medicine and Biology 469 623 630 10667391 1:CAS:528:DC%2BD3cXotVKhu70%3D
42. D Nie J Nemeth Y Qiao A Zacharek L Li K Hanna, et al. 2003 Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase Clinical & Experimental Metastasis 20 7 657 663 1:CAS:528:DC%2BD3sXos1amt78%3D
43. S Gupta M Srivastava N Ahmad DG Bostwick H Mukhtar 2000 Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma The Prostate 42 1 73 78 10579801 1:CAS:528:DC%2BD3cXisVCqtw%3D%3D
44. LM Lee CC Pan CJ Cheng CW Chi TY Liu 2001 Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia Anticancer Research 21 1291 1294 11396201 1:STN:280:DC%2BD3MzivVyhuw%3D%3D
45. D Nie M Che A Zacharek Y Qiao L Li X Li, et al. 2004 Differential expression of thromboxane synthase in prostate carcinoma: Role in tumor cell motility American Journal of Pathology 164 2 429 439 10.1016/s0002-9440(10) 63133-1 14742249 1:CAS:528:DC%2BD2cXhsFGqs7g%3D
46. Dassesse, T., de Leval, X., de Leval, L., Pirotte, B., Castronovo, V., & Waltregny, D. (2006). Activation of the thromboxane A2 pathway in human prostate cancer correlates with tumor Gleason score and pathologic stage. Eur Urol, 50(5), 1021-1031; discussion 1031, doi: 10.1016/j.eururo.2006.01.036.
47. A Villers JE McNeal EA Redwine FS Freiha TA Stamey 1989 The role of perineural space invasion in the local spread of prostatic adenocarcinoma Journal of Urology 142 3 763 768 2769857 1:STN:280:DyaL1Mzmt1Kluw%3D%3D
48. Pantel, K., & Brakenhoff, R. H. (2004). Dissecting the metastatic cascade. [Review]. Nature reviews. Cancer, 4(6), 448-456, doi: 10.1038/nrc1370.
49. D Nie Y Guo D Yang Y Tang Y Chen MT Wang, et al. 2008 Thromboxane A2 receptors in prostate carcinoma: Expression and its role in regulating cell motility via small GTPase Rho Cancer Research 68 1 115 121 10.1158/0008-5472. can-07-1018 18172303 1:CAS:528:DC%2BD1cXos12i
50. P Kelly LN Stemmle JF Madden TA Fields Y Daaka PJ Casey 2006 A role for the G12 family of heterotrimeric G proteins in prostate cancer invasion Journal of Biological Chemistry 281 36 26483 26490 10.1074/jbc.M604376200 16787920 1:CAS:528:DC%2BD28XovFyqu78%3D
51. EC Turner DJ Kavanagh EP Mulvaney C McLean K Wikstrom HM Reid, et al. 2011 Identification of an interaction between the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor with protein kinase C-related kinase (PRK) 1: Implications for prostate cancer Journal of Biological Chemistry 286 17 15440 15457 10.1074/jbc.M110.181180 21357687 1:CAS:528:DC%2BC3MXltVWjsr0%3D
52. G Watkins A Douglas-Jones RE Mansel WG Jiang 2005 Expression of thromboxane synthase, TBXAS1 and the thromboxane A2 receptor, TBXA2R, in human breast cancer International Seminars in Surgical Oncology 2 23 10.1186/1477-7800-2-23 16250911
53. P Kelly BJ Moeller J Juneja MA Booden CJ Der Y Daaka, et al. 2006 The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis Proceedings of the National Academy of Sciences of the United States of America 103 21 8173 8178 10.1073/pnas.0510254103 16705036 1:CAS:528:DC%2BD28Xlt1Ohur8%3D
54. JE Abraham P Harrington KE Driver J Tyrer DF Easton AM Dunning, et al. 2009 Common polymorphisms in the prostaglandin pathway genes and their association with breast cancer susceptibility and survival Clinical Cancer Research 15 6 2181 2191 10.1158/1078-0432.CCR-08-0716 19276290 1:CAS:528:DC%2BD1MXjtF2ru7Y%3D
55. L Ermert C Dierkes M Ermert 2003 Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors Clinical Cancer Research 9 5 1604 1610 12738712 1:CAS:528:DC%2BD3sXjsFeisbs%3D
56. M Kreutzer T Fauti K Kaddatz C Seifart A Neubauer H Schweer, et al. 2007 Specific components of prostanoid-signaling pathways are present in non-small cell lung cancer cells Oncology Reports 18 2 497 501 17611676 1:CAS:528:DC%2BD2sXpsFGlu7k%3D
57. A Yoshimoto K Kasahara A Kawashima M Fujimura S Nakao 2005 Characterization of the prostaglandin biosynthetic pathway in non-small cell lung cancer: A comparison with small cell lung cancer and correlation with angiogenesis, angiogenic factors and metastases Oncology Reports 13 6 1049 1057 15870920 1:CAS:528:DC%2BD2MXltV2lurs%3D
58. J Wei W Yan X Li Y Ding HH Tai 2010 Thromboxane receptor alpha mediates tumor growth and angiogenesis via induction of vascular endothelial growth factor expression in human lung cancer cells Lung Cancer 69 1 26 32 10.1016/j.lungcan.2009.09.009 19853959
59. J Wei W Yan X Li WC Chang HH Tai 2007 Activation of thromboxane receptor alpha induces expression of cyclooxygenase-2 through multiple signaling pathways in A549 human lung adenocarcinoma cells Biochemical Pharmacology 74 5 787 800 10.1016/j.bcp. 2007.06.008 17632087 1:CAS:528:DC%2BD2sXotlajs7o%3D
60. X Li HH Tai 2009 Activation of thromboxane A(2) receptors induces orphan nuclear receptor Nurr1 expression and stimulates cell proliferation in human lung cancer cells Carcinogenesis 30 9 1606 1613 10.1093/carcin/bgp161 19570744
61. D Nie M Lamberti A Zacharek L Li K Szekeres K Tang, et al. 2000 Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis Biochemical and Biophysical Research Communications 267 1 245 251 10.1006/bbrc.1999.1840 10623605 1:CAS:528:DC%2BD3cXht1GhsA%3D%3D
62. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 1 57 70 10647931 1:CAS:528:DC%2BD3cXks1CktA%3D%3D [Review]
63. M Fujimura K Kasahara H Shirasaki U Heki K Iwasa A Ueda, et al. 1999 Up-regulation of ICH-1 L protein by thromboxane A2 antagonists enhances cisplatin-induced apoptosis in non-small-cell lung-cancer cell lines Journal of Cancer Research and Clinical Oncology 125 7 389 394 10394958 1:CAS:528:DyaK1MXktVSqsL4%3D
64. KC Leung MK Hsin JS Chan JH Yip M Li BC Leung, et al. 2009 Inhibition of thromboxane synthase induces lung cancer cell death via increasing the nuclear p27 Experimental cell research 315 17 2974 2981 10.1016/j.yexcr.2009.06.025 19576211 1:CAS:528:DC%2BD1MXht1aisLrL [Research Support, Non-U.S. Gov't]
65. KC Leung MY Li BC Leung MK Hsin TS Mok MJ Underwood, et al. 2010 Thromboxane synthase suppression induces lung cancer cell apoptosis via inhibiting NF-kappaB Experimental Cell Research 316 20 3468 3477 20647010 1:CAS:528:DC%2BC3cXhtl2gu73E
66. TL McLemore WC Hubbard CL Litterst MC Liu S Miller NA McMahon, et al. 1988 Profiles of prostaglandin biosynthesis in normal lung and tumor tissue from lung cancer patients Cancer Research 48 11 3140 3147 3130187 1:CAS:528:DyaL1cXkt1WjsL0%3D
67. RY Huang MY Li MK Hsin MJ Underwood LT Ma TS Mok, et al. 2011 4-Methylnitrosamino-1-3-pyridyl-1-butanone (NNK) promotes lung cancer cell survival by stimulating thromboxane A2 and its receptor Oncogene 30 1 106 116 10.1038/onc.2010.390 20818420 1:CAS:528:DC%2BC3cXhtFWksrvL [Research Support, Non-U.S. Gov't]
68. MC Cathcart K Gately R Cummins E Kay KJ O'Byrne GP Pidgeon 2011 Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer Molecular Cancer 10 25 21388528 1:CAS:528:DC%2BC3MXjslKltr0%3D
69. AJ McAfee EM McSorley GJ Cuskelly BW Moss JM Wallace MP Bonham, et al. 2010 Red meat consumption: An overview of the risks and benefits Meat science 84 1 1 13 j.meatsci.2009.08.029 20374748 1:CAS:528:DC%2BD1MXht1GmsbfP [Review]
70. RJ Bing M Miyataka KA Rich N Hanson X Wang HD Slosser, et al. 2001 Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancer Clinical Cancer Research 7 11 3385 3392 11705852 1:CAS:528:DC%2BD3MXptFaju7c%3D
71. M Tsujii S Kawano RN DuBois 1997 Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential Proceedings of the National Academy of Sciences of the United States of America 94 7 3336 3340 9096394 1:CAS:528:DyaK2sXisVKnsr8%3D
72. P Pradono R Tazawa M Maemondo M Tanaka K Usui Y Saijo, et al. 2002 Gene transfer of thromboxane A(2) synthase and prostaglandin I(2) synthase antithetically altered tumor angiogenesis and tumor growth Cancer Research 62 1 63 66 11782360 1:CAS:528:DC%2BD38XntV2jtg%3D%3D
73. A Gustafsson E Hansson U Kressner S Nordgren M Andersson C Lonnroth, et al. 2007 Prostanoid receptor expression in colorectal cancer related to tumor stage, differentiation and progression Acta Oncologica 46 8 1107 1112 10.1080/02841860701403061 17943472 1:CAS:528:DC%2BD2sXht1GrsrnK
74. H Sakai T Suzuki Y Takahashi M Ukai K Tauchi T Fujii, et al. 2006 Upregulation of thromboxane synthase in human colorectal carcinoma and the cancer cell proliferation by thromboxane A2 FEBS Letters 580 14 3368 3374 10.1016/j.febslet.2006.05.007 16709411 1:CAS:528:DC%2BD28Xltlens70%3D
75. S Sathornsumetee JN Rich 2006 New treatment strategies for malignant gliomas Expert Review of Anticancer Therapy 6 7 1087 1104 10.1586/14737140.6.7. 1087 16831080 1:CAS:528:DC%2BD28XnvVeqtb4%3D [Review]
76. W McDonough N Tran A Giese SA Norman ME Berens 1998 Altered gene expression in human astrocytoma cells selected for migration: I. Thromboxane synthase Journal of Neuropathology and Experimental Neurology 57 5 449 455 9596415 1:CAS:528:DyaK1cXjsVWhtLs%3D
77. A Giese C Hagel EL Kim S Zapf J Djawaheri ME Berens, et al. 1999 Thromboxane synthase regulates the migratory phenotype of human glioma cells Neuro-Oncology 1 1 3 13 11550298 1:STN:280:DC%2BD3MrgtFCksw%3D%3D
78. AK Schauff EL Kim J Leppert R Nadrowitz R Wuestenberg MA Brockmann, et al. 2009 Inhibition of invasion-associated thromboxane synthase sensitizes experimental gliomas to gamma-radiation Journal of Neuro-Oncology 91 3 241 249 10.1007/s11060-008-9708-0 18825315 1:CAS:528:DC%2BD1MXjvFemtg%3D%3D
79. R Stupp WP Mason MJ van den Bent M Weller B Fisher MJ Taphoorn, et al. 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma The New England Journal of Medicine 352 10 987 996 10.1056/NEJMoa043330 15758009 1:CAS:528:DC%2BD2MXit1Wksbk%3D
80. NO Schmidt M Ziu T Cargioli M Westphal A Giese PM Black, et al. 2010 Inhibition of thromboxane synthase activity improves glioblastoma response to alkylation chemotherapy Translational Oncology 3 1 43 49 20165694
81. ME Hegi AC Diserens T Gorlia MF Hamou N de Tribolet M Weller, et al. 2005 MGMT gene silencing and benefit from temozolomide in glioblastoma The New England Journal of Medicine 352 10 997 1003 10.1056/NEJMoa043331 15758010 1:CAS:528:DC%2BD2MXit1Wktro%3D
82. R Gangwar A Mandhani RD Mittal 2011 Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for urinary bladder cancer in North India Surgery 149 1 126 134 20627335 [Comparative Study]
83. A Danon TV Zenser DL Thomasson BB Davis 1986 Eicosanoid synthesis by cultured human urothelial cells: Potential role in bladder cancer Cancer Research 46 11 5676 5681 3093068 1:CAS:528:DyaL28Xmt1ektrk%3D
84. O Moussa JM Riker J Klein M Fraig PV Halushka DK Watson 2008 Inhibition of thromboxane synthase activity modulates bladder cancer cell responses to chemotherapeutic agents Oncogene 27 1 55 62 10.1038/sj.onc.1210629 17603559 1:CAS:528:DC%2BD1cXhtlSgug%3D%3D
85. O Moussa JS Yordy H Abol-Enein D Sinha NK Bissada PV Halushka, et al. 2005 Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer Cancer Research 65 24 11581 11587 10.1158/0008-5472.can-05-1622 16357168 1:CAS:528:DC%2BD2MXhtlWiu7rM
86. O Moussa AW Ashton M Fraig E Garrett-Mayer MA Ghoneim PV Halushka, et al. 2008 Novel role of thromboxane receptors beta isoform in bladder cancer pathogenesis Cancer Research 68 11 4097 4104 10.1158/0008-5472.can-07-6560 18519668 1:CAS:528:DC%2BD1cXmsFKmtL8%3D
87. S Patan 2004 Vasculogenesis and angiogenesis Cancer Treatment and Research 117 3 32 15015550 1:CAS:528:DC%2BD2cXptFKiuro%3D
88. AW Ashton R Yokota G John S Zhao SO Suadicani DC Spray, et al. 1999 Inhibition of endothelial cell migration, intercellular communication, and vascular tube formation by thromboxane A(2) Journal of Biological Chemistry 274 50 35562 35570 10585431 1:CAS:528:DyaK1MXotVGnsLc%3D
89. 2 receptor signaling inhibits vascular endothelial growth factor-induced endothelial cell differentiation and migration Circulation Research 95 372 379 15242977 1:CAS:528:DC%2BD2cXmsVKlu7k%3D
90. 2 receptor agonists antagonize the proangiogenic effects of fibroblast growth factor-2: role of receptor internalization, thrombospondin-1, and αvβ3 Circulation Research 94 735 742 14963009 1:CAS:528: DC%2BD2cXisFOhtL4%3D
91. Y Gao R Yokota S Tang AW Ashton JA Ware 2000 Reversal of angiogenesis in vitro, induction of apoptosis, and inhibition of AKT phosphorylation in endothelial cells by thromboxane A(2) Circulation Research 87 9 739 745 11055976 1:CAS:528:DC%2BD3cXnvVOlurc%3D
92. MH Beauchamp AK Martinez-Bermudez F Gobeil Jr AM Marrache X Hou G Speranza, et al. 2001 Role of thromboxane in retinal microvascular degeneration in oxygen-induced retinopathy Journal of Applied Physiology 90 6 2279 2288 11356793 1:CAS:528:DC%2BD3MXksFansL0%3D
93. JP De La Cruz A Moreno MI Ruiz-Ruiz F Sanchez De La Cuesta 2000 Effect of DT-TX 30, a combined thromboxane synthase inhibitor and thromboxane receptor antagonist, on retinal vascularity in experimental diabetes mellitus Thrombosis Research 97 3 125 131
94. MH Zou C Shi RA Cohen 2002 High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H(2) receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells Diabetes 51 1 198 203 11756341 1:CAS:528:DC%2BD38Xlt1ehtQ%3D%3D
95. Y Kishi F Numano 1989 In vitro study of vascular endothelial injury by activated platelets and its prevention Atherosclerosis 76 2-3 95 101 2543423 1:CAS:528:DyaL1MXkt1Wmtbw%3D
96. S Pal J Wu JK Murray SH Gellman MA Wozniak PJ Keely, et al. 2006 An antiangiogenic neurokinin-B/thromboxane A2 regulatory axis The Journal of Cell Biology 174 7 1047 1058 10.1083/jcb.200603152 17000881 1:CAS:528: DC%2BD28Xht12ht7bO
97. RA Benndorf E Schwedhelm A Gnann R Taheri G Kom M Didié, et al. 2008 Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A2 receptor. A potential link between oxidative stress and impaired angiogenesis Circulation Research 103 1037 1046 18802021 1:CAS:528:DC%2BD1cXht1CqtrjP
98. TO Daniel H Liu JD Morrow BC Crews LJ Marnett 1999 Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis Cancer Research 59 18 4574 4577 10493510 1:CAS:528:DyaK1MXmtVKksbk%3D
99. T Sakurai K Tamura H Kogo 2005 Stimulatory effects of eicosanoids on ovarian angiogenesis in early luteal phase in cyclooxygenase-2 inhibitor-treated rats European Journal of Pharmacology 516 2 158 164 15921676 1:CAS:528:DC%2BD2MXltFSqsbw%3D
100. X de Leval T Dassesse JM Dogne D Waltregny A Bellahcene V Benoit, et al. 2006 Evaluation of original dual thromboxane A2 modulators as antiangiogenic agents Journal of Pharmacology and Experimental Therapeutics 318 3 1057 1067 10.1124/jpet.106.101188 16720756
101. B Rocca AL Loeb JF Strauss 3rd R Vezza A Habib H Li, et al. 2000 Directed vascular expression of the thromboxane A2 receptor results in intrauterine growth retardation Nature Medicine 6 2 219 221 10655114 1:CAS:528: DC%2BD3cXosF2jtQ%3D%3D
102. SJ Wilson K McGinley AJ Huang EM Smyth 2007 Heterodimerization of the alpha and beta isoforms of the human thromboxane receptor enhances isoprostane signaling Biochemical and Biophysical Research Communications 352 2 397 403 17134677 1:CAS:528:DC%2BD28XhtlShsr%2FF
103. JL Parent P Labrecque MJ Orsini JL Benovic 1999 Internalization of the TXA2 receptor alpha and beta isoforms. Role of the differentially spliced cooh terminus in agonist-promoted receptor internalization Journal of Biological Chemistry 274 13 8941 8948 10085139 1:CAS:528:DyaK1MXitFyrtbg%3D
104. JL Parent P Labrecque M Driss Rochdi JL Benovic 2001 Role of the differentially spliced carboxyl terminus in thromboxane A2 receptor trafficking: Identification of a distinct motif for tonic internalization Journal of Biological Chemistry 276 10 7079 7085 11112783 1:CAS:528:DC%2BD3MXitVKlt7g%3D
105. MD Rochdi G Laroche E Dupre P Giguere A Lebel V Watier, et al. 2004 Nm23-H2 interacts with a G protein-coupled receptor to regulate its endocytosis through an Rac1-dependent mechanism Journal of Biological Chemistry 279 18 18981 18989 14976202 1:CAS:528:DC%2BD2cXjsVKmt7o%3D
106. C Theriault MD Rochdi JL Parent 2004 Role of the Rab11-associated intracellular pool of receptors formed by constitutive endocytosis of the beta isoform of the thromboxane A2 receptor (TP beta) Biochemistry 43 19 5600 5607 15134434 1:CAS:528:DC%2BD2cXjtlCnsrw%3D
107. HM Reid K Wikstrom DJ Kavanagh EP Mulvaney BT Kinsella 2011 Interaction of angio-associated migratory cell protein with the TPalpha and TPbeta isoforms of the human thromboxane A receptor Cellular Signalling 23 4 700 717 21172430 1:CAS:528:DC%2BC3MXht1yrur8%3D
108. KV Honn B Cicone A Skoff 1981 Prostacyclin: A potent antimetastatic agent Science 212 4500 1270 1272 7015512 1:CAS:528:DyaL3MXktlKjtr0%3D
109. DG Menter JM Onoda JD Taylor KV Honn 1984 Effects of prostacyclin on tumor cell-induced platelet aggregation Cancer Research 44 2 450 456 6362850 1:CAS:528:DyaL2cXpsleltw%3D%3D